CY1121174T1 - 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDS AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDS AS BTC INhibitors - Google Patents
4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDS AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDS AS BTC INhibitorsInfo
- Publication number
- CY1121174T1 CY1121174T1 CY20191100084T CY191100084T CY1121174T1 CY 1121174 T1 CY1121174 T1 CY 1121174T1 CY 20191100084 T CY20191100084 T CY 20191100084T CY 191100084 T CY191100084 T CY 191100084T CY 1121174 T1 CY1121174 T1 CY 1121174T1
- Authority
- CY
- Cyprus
- Prior art keywords
- benzamids
- imidazotriazin
- imidazopyridazin
- btc
- inhibitors
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Η παρούσα εφεύρεση σχετίζεται με ενώσεις 6-5μελούς συντηγμένου δακτυλίου πυριδίνης σύμφωνα με τον τύπο (I), ή ένα φαρμακευτικά αποδεκτό άλας αυτών, ή με φαρμακευτικές συνθέσεις που περιέχουν αυτές τις ενώσεις και με τη χρήση τους στη θεραπεία. Ειδικότερα, η παρούσα εφεύρεση σχετίζεται με τη χρήση ενώσεων 6-5 μελούς συντηγμένου δακτυλίου πυριδίνης σύμφωνα με τον τύπο I στη θεραπεία προκαλούμενων από Τυροσινική Κινάση του Βruton (Btk) διαταραχών.The present invention relates to compounds of 6-5 membered fused pyridine rings according to formula (I), or a pharmaceutically acceptable salt thereof, or to pharmaceutical compositions containing these compounds and for use in therapy. More particularly, the present invention relates to the use of compounds of 6-5 membered fused pyridine ring according to formula I in the treatment of Bruton Tyrosine Kinase (Btk) disorders.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161509397P | 2011-07-19 | 2011-07-19 | |
| EP11174578 | 2011-07-19 | ||
| EP12733505.7A EP2734522B1 (en) | 2011-07-19 | 2012-07-11 | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors |
| PCT/EP2012/063552 WO2013010868A1 (en) | 2011-07-19 | 2012-07-11 | 4 - imidazopyridazin- 1 -yl-benzamides and 4 - imidazotriazin- 1 - yl - benzamides as btk- inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1121174T1 true CY1121174T1 (en) | 2020-05-29 |
Family
ID=67956153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191100084T CY1121174T1 (en) | 2011-07-19 | 2019-01-22 | 4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDS AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDS AS BTC INhibitors |
Country Status (8)
| Country | Link |
|---|---|
| CY (1) | CY1121174T1 (en) |
| LT (2) | LT3689878T (en) |
| ME (1) | ME03310B (en) |
| NI (1) | NI201400004A (en) |
| NL (1) | NL301097I2 (en) |
| NO (1) | NO2021016I1 (en) |
| PT (1) | PT2734522T (en) |
| TR (1) | TR201901013T4 (en) |
-
2012
- 2012-07-11 LT LTEP19215783.2T patent/LT3689878T/en unknown
- 2012-07-11 ME MEP-2019-4A patent/ME03310B/en unknown
- 2012-07-11 TR TR2019/01013T patent/TR201901013T4/en unknown
- 2012-07-11 PT PT12733505T patent/PT2734522T/en unknown
-
2014
- 2014-01-17 NI NI201400004A patent/NI201400004A/en unknown
-
2019
- 2019-01-22 CY CY20191100084T patent/CY1121174T1/en unknown
-
2021
- 2021-03-22 NL NL301097C patent/NL301097I2/en unknown
- 2021-03-24 LT LTPA2021004C patent/LTC2734522I2/en unknown
- 2021-04-09 NO NO2021016C patent/NO2021016I1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NI201400004A (en) | 2014-10-10 |
| PT2734522T (en) | 2019-02-04 |
| LT3689878T (en) | 2021-11-25 |
| NL301097I1 (en) | 2021-03-24 |
| LTPA2021004I1 (en) | 2021-04-12 |
| NO2021016I1 (en) | 2021-04-09 |
| LTC2734522I2 (en) | 2022-09-26 |
| ME03310B (en) | 2019-10-20 |
| TR201901013T4 (en) | 2019-02-21 |
| NL301097I2 (en) | 2021-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500166A1 (en) | 4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides as btk-inhibitors | |
| CY1122966T1 (en) | 5-BROMO-2,6-DI-(1H-PYRAZOL-1-YL)PYRIMIDIN-4-AMINE FOR USE IN THE THERAPEUTIC TREATMENT OF CANCER | |
| CY1121418T1 (en) | HEPATITIS VIRUS INHIBITORS C | |
| CY1122730T1 (en) | 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND THEIR USES | |
| CY1121150T1 (en) | NEUROACTIVE 19-ALCOXY-17-SUBSTITUTED STEROIDS, USEFUL IN TREATMENT METHODS | |
| CY1119490T1 (en) | PYRAZOLOPYROLIDINE PRODUCTS AND THEIR USE IN PATIENT TREATMENT | |
| EA201592200A1 (en) | DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B | |
| EA201690752A1 (en) | INHIBITORS G12C KRAS | |
| EA201591890A1 (en) | DERIVATIVES N-PHENYLCARBOXAMIDE AND THEIR USE AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B | |
| EA201792116A1 (en) | JANUS KINASE INHIBITOR | |
| UA109010C2 (en) | Morpholino pyrividines and their use in therapy | |
| EA201891063A1 (en) | DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER | |
| EA201591195A1 (en) | NEW QUINOLON DERIVATIVES | |
| EA201500298A1 (en) | ALCOXYPHAZOLES AS ACTIVATORS OF SOLUBLE GUANYLATZYCLASES | |
| EA201370166A1 (en) | CONTAINING DIRYLACETHYLENEHYDRAZIDE THYROZINKINASE INHIBITORS | |
| EA201490471A1 (en) | PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS | |
| EA201591371A1 (en) | Pyridine derivatives as easily degraded inhibitors ROCK | |
| EA201591301A1 (en) | NEW PYRIMIDINE AND PYRIDINE CONNECTIONS AND THEIR APPLICATION | |
| CY1116775T1 (en) | Pyrimidone derivatives as inhibitors of viral transglutaminase | |
| EA201600337A1 (en) | 2,6-SUBSTITUTED PURINE DERIVATIVES AND THEIR APPLICATION IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
| CY1119391T1 (en) | OXAZOLIDIN-2-ONY-PYRIMIDINE PRODUCTS | |
| EA201792689A1 (en) | DERIVATIVES 2- (PYRAZOLOPIRIDIN-3-IL) Pyrimidine as inhibitors of JAK | |
| TW201613864A (en) | Novel compounds | |
| EA201790949A1 (en) | SUBSTITUTED 2,4-DIAMINOCHINOLINES AS NEW ANTI-CANCER FACILITIES | |
| CY1122077T1 (en) | NEW CYCLED PHENOXYACETAMIDIES |